Skip to main content
. 2018 Nov 12;294(1):157–167. doi: 10.1074/jbc.RA118.005041

Table 2.

Midpoint reduction potentials of ferric-siderophores used in this study

Siderophore pH, temperature E1/2 (mV vs SHE) Reference
Avaroferrin 7.25, 25 °C −295 and +25 This study
Bisucaberin 7.30, 25 °C −311 and +35 This study
Ferrioxamine E 10.5, NDa −478 30
Putrebactin 7.27, 25 °C −309 and +33 This study

a ND, not determined.